Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Why is the FDA refusing Moderna's application for a new mRNA flu vaccine?
05:10am, Thursday, 12'th Feb 2026
The U.S. Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.The news is the l
The head of the agency's vaccine division, Vinay Prasad, has overruled pushback from career staffers.
Market Today: Jobs Beat Sways Stocks; MCD, WBD in Focus
05:36pm, Wednesday, 11'th Feb 2026
Guru Stock PicksCatherine Wood has made the following transactions:Reduce in NXDR by 2.41%Sold out in KMDAAdd in FVRR by 24%New position in IWBPRIMECAP Manageme
FDA blindsides Moderna with refusal to review flu vaccine application: ‘We're pretty confused'
03:15pm, Wednesday, 11'th Feb 2026
The new shot was not compared to “the best-available standard of care in the United States at the time of the study,” an FDA official told Moderna.
Moderna's investigational flu vaccine denied FDA review, shares drop
01:03pm, Wednesday, 11'th Feb 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has issue
Why Moderna Stock Is Sinking Today
12:29pm, Wednesday, 11'th Feb 2026
Moderna (MRNA) shares slid about 10% in U.S. premarket trading Wednesday after the U.S. Food and Drug Administration declined to review its application for seas
MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA
11:45am, Wednesday, 11'th Feb 2026
Moderna shares sink 10% after FDA issues Refusal-to-File letter for its mRNA-1010 flu vaccine, citing trial design concerns despite no safety flags.
Moderna Stock Alert: - Kehoe Law Firm, P.C. Investigating Securities Claims on Behalf of Moderna Investors - MRNA
10:46am, Wednesday, 11'th Feb 2026
Philadelphia, Pennsylvania--(Newsfile Corp. - February 11, 2026) - Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf
Moderna's work developing seasonal vaccines is ‘risky' under current FDA, analyst says
10:44am, Wednesday, 11'th Feb 2026
The biotech company said the FDA won't review its flu vaccine, in the latest hit to mRNA development.
Stock Futures Jump on Strong January Jobs Report
09:20am, Wednesday, 11'th Feb 2026
Stock futures are higher this morning after strong jobs data
Moderna's investigational flu vaccine denied FDA review, shares drop
08:00am, Wednesday, 11'th Feb 2026
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug Administration’s (FDA) Center for...
First Look: Jobs Data Looms; WBD-NFLX Fight, Moderna Setback
07:40am, Wednesday, 11'th Feb 2026
Stock News FDA refuses to file Moderna's flu shot: Moderna (MRNA) said the FDA issued a refusal-to-file letter for its mRNA flu vaccine application, citing tria
Breakfast News: First SaaS, Now Finance Hit By AI
07:30am, Wednesday, 11'th Feb 2026
AI makes move into tax planning, Shopify and Unity report this morning, and more
Moderna Stock Sinks. The FDA Delivers a Blow to Its New Flu Vaccine.
07:05am, Wednesday, 11'th Feb 2026
The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.
Wall Street Breakfast Podcast: Amazon Adds BETA To Cart
06:24am, Wednesday, 11'th Feb 2026
Amazon (AMZN) acquires a 5.3% stake in BETA Technologies, sharply boosting BETA's premarket share price. Moderna (MRNA) faces an FDA refusal-to-file for its mRNA-1010 influenza vaccine, citing inadequ
